BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 5, 2002
View Archived Issues
NNC-45-0781, a promising candidate for postmenopausal osteoporosis
Read More
Antitumor effects demonstrated for rapamycin at immunosuppressive doses
Read More
Influenza vaccination reduces risk of brain infarction according to French researchers
Read More
Seattle Genetics and Genencor jointly develop ADEPT products including SGN-17/19
Read More
FDA approves BioPort anthrax vaccine license supplements
Read More
Preclinical evidence for efficacy of celecoxib in inflammatory bowel disease
Read More
Forbes Medi-Tech initiates phase I trial of cholesterol-lowering pharmaceutical
Read More
AltaRex offers further analysis of OvaRex results
Read More
Corixa reports progress in 2001
Read More
Malarex: a natural alternative in the fight against malaria
Read More
Chiron and Global Alliance for TB Drug Development collaborate on PA-824
Read More
Gleevec approved for gastrointestinal stromal tumors
Read More
National Institute on Aging studies genetic traits in Sardinians
Read More
Oxigene highlights product developments in fourth quarter 2001
Read More
First approval obtained for antihypertensive combination developed in Spain
Read More
Clinical testing of candidate HIV vaccine developed at GSK commences in U.S.
Read More
Tricyclic compounds that inhibit MRP-1 are useful as oncolytics
Read More
Radiolabeled nucleoside compounds for use as cancer imaging and therapeutic agents
Read More
Corixa designs isoleucine-containing peptide prodrugs of antitumor agents
Read More
Quinazoline derivatives that act as NPY antagonists for eating disorders, etc.
Read More
Preparation and use of pipecolic acid derivatives with MMP-inhibitory activity
Read More
Aromatic alphavbeta3 and/or alphavbeta5 integrin receptor antagonists disclosed by Pharmacia
Read More
